Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
C7H15O3SNa
CAS Number:
Molecular Weight:
202.25
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12161900
EC Number:
245-210-5
MDL number:
description
anionic
Quality Level
product line
BioXtra
mol wt
202.25 g/mol
impurities
<0.001% Phosphorus (P), <0.1% Insoluble matter
solubility
H2O: 0.5 M at 20 °C, clear, colorless
anion traces
chloride (Cl-): <0.05%
cation traces
Al: <0.0005%, Ca: <0.005%, Cu: <0.0005%, Fe: <0.0005%, K: <0.005%, Mg: <0.0005%, NH4+: <0.05%, Pb: <0.001%, Zn: <0.0005%
SMILES string
[Na+].CCCCCCCS([O-])(=O)=O
InChI
1S/C7H16O3S.Na/c1-2-3-4-5-6-7-11(8,9)10;/h2-7H2,1H3,(H,8,9,10);/q;+1/p-1
InChI key
REFMEZARFCPESH-UHFFFAOYSA-M
Application
Ion-pairing reagent for HPLC, including analyses of peptides and proteins.
Still not finding the right product?
Explore all of our products under Sodium 1-heptanesulfonate
Storage Class
11 - Combustible Solids
wgk
WGK 2
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Takeshi Oshizaka et al.
International journal of pharmaceutics, 475(1-2), 292-297 (2014-08-27)
Skin concentrations of topically administered compounds need to be considered in order to evaluate their efficacies and toxicities. This study investigated the relationship between the skin permeation and concentrations of compounds, and also predicted the skin concentrations of these compounds
Marianna Sikorska et al.
Neurobiology of aging, 35(10), 2329-2346 (2014-04-30)
Although the support for the use of antioxidants, such as coenzyme Q(10) (CoQ(10)), to treat Parkinson's disease (PD) comes from the extensive scientific evidence, the results of conducted thus far clinical trials are inconclusive. It is assumed that the efficacy
Miriam Dadparvar et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 88(2), 510-517 (2014-07-06)
Severe intoxications with organophosphates require the immediate administration of atropine in combination with acetyl cholinesterase (AChE) reactivators such as HI-6. Although this therapy regimen enables the treatment of peripheral symptoms, the blood-brain barrier (BBB) restricts the access of the hydrophilic
Global Trade Item Number
| SKU | GTIN |
|---|---|
| H8901-5G | 04061833811627 |
| H8901-25G | 04061833811603 |